SUBLICENSE AGREEMENTSublicense Agreement • January 21st, 2009 • Impax Laboratories Inc • Pharmaceutical preparations
Contract Type FiledJanuary 21st, 2009 Company IndustryThis Sublicense Agreement (the “Agreement”), effective as of March 30, 2007 (the “Effective Date”), is by and between DAVA Pharmaceuticals, Inc., a Delaware corporation (“DAVA”), and IMPAX Laboratories, Inc., a Delaware corporation (“IMPAX”).
SUBLICENSE AGREEMENTSublicense Agreement • January 14th, 2009 • Impax Laboratories Inc • Pharmaceutical preparations
Contract Type FiledJanuary 14th, 2009 Company IndustryThis Sublicense Agreement (the “Agreement”), effective as of March 30, 2007 (the “Effective Date”), is by and between DAVA Pharmaceuticals, Inc., a Delaware corporation (“DAVA”), and IMPAX Laboratories, Inc., a Delaware corporation (“IMPAX”).
SUBLICENSE AGREEMENTSublicense Agreement • November 12th, 2008 • Impax Laboratories Inc • Pharmaceutical preparations
Contract Type FiledNovember 12th, 2008 Company IndustryThis Sublicense Agreement (the “Agreement”), effective as of March 30, 2007 (the “Effective Date”), is by and between DAVA Pharmaceuticals, Inc., a Delaware corporation (“DAVA”), and IMPAX Laboratories, Inc., a Delaware corporation (“IMPAX”).